“ASSESSMENT OF SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) AS A POTENTIAL RISK MARKER IN OBESE WOMEN WITH PREDICTIVE MARKER FOR POLYCYSTIC OVARY SYNDROME”. CAHIERS MAGELLANES-NS 6, no. 2 (September 2, 2024): 4972–4983. Accessed August 22, 2025. http://cahiersmagellanes.com/index.php/CMN/article/view/782.